Date: Wednesday 12 October 2016
Venue: Queen Elizabeth II Conference Centre, London
To download the final programme, please click on the icon on the right hand side.
To view presentations from the BHIVA Autumn Conference 2016, please click here.
Welcome and Introduction
Dr Sanjay Bhagani
Royal Free London NHS Foundation Trust
Dr Andrew Ustianowski
North Manchester General Hospital
Session 1: Advances in viral hepatitis management: Bench to clinic
Upcoming HCV therapy and ‘difficult-to-treat patients’
Professor Graham Foster, Queen Mary University of London
Resistance testing in HCV infection – is it necessary?
Professor Jean-Michel Pawlotsky, Hôpital Henri-Mondor, Paris, France
New paradigms in HBV management
Professor Geoff Dusheiko, Royal Free London NHS Foundation Trust
Panel Discussion
Session 2: HIV/Hepatitis co-infection clinical case presentations
Case report: a treatment dilemma
Dr Chris Dugan, Royal Free London NHS Foundation Trust
Fallen at the first hurdle
Dr Sarah Ramsay, Barts Health NHS Trust, London
A wild goose chase
Dr Diarmuid Nugent, Mortimer Market Centre, London
Session 3: UK CHIC Viral Hepatitis Programme
Introduction
Professor Caroline Sabin, University College London
Summary of ongoing/completed UK CHIC work
Update on the epidemiology of HBV/HCV in the UK CHIC cohort
Ms Alicia Thornton, University College London
Treatment uptake and outcomes for HCV
Dr Richard Gilson, University College London
ESLD: referral for transplantation and outcomes
Dr Charlotte Warren-Gash, University College London
Looking forwards: how can we benefit with wider collaborations?
HCV research/stop HCV
Professor William Irving, University of Nottingham
Modelling work
Professor Peter Vickerman, University of Bristol
Collaborations with PHE
Dr Ruth Simmons, Public Health England
Panel Discussion
Session 4: Non-viral Liver Disease
Non-alcoholic fatty liver: a practical approach
Professor Mark Thursz, University College London
How important is alcohol as a contributor to liver disease in patients with viral hepatitis and HIV?
Dr Vincent Mallet, Université Paris Descartes, France
Keynote Lecture: Global Issues in HCV
Elimination of HCV: a reality?
Dr Gail Matthews, University of New South Wales, Australia
Gilead Sciences have made a contribution towards the funding of this lecture. Gilead Sciences have had no involvement with the selection of the speaker or content of this lecture.
Case presentation prize and close by the Chair of the British Viral Hepatitis Group
Dr Andrew Ustianowski
North Manchester General Hospital
Conference Sponsors